Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Adult acute myeloid leukemia Jabbour EJ; Estey E; Kantarjian HMMayo Clin Proc 2006[Feb]; 81 (2): 247-60Acute myeloid leukemia (AML) is a group of several different diseases, the treatment and outcome of which depend on several factors, including leukemia karyotype, patient age, and comorbid conditions. Despite advances in understanding the molecular biology of AML, its treatment remains challenging. Standard regimens using cytarabine and anthracyclines for induction followed by some form of postremission therapy produce response rates of 60% to 70%, with less than 20% of all patients achieving long-term disease-free survival. New therapies are emerging based on the definition of specific cytogenetic-molecular abnormalities. Such targeted therapies offer the promise of better antileukemic activity in adult AML.|Acute Disease[MESH]|Adult[MESH]|Aged[MESH]|Anthracyclines/therapeutic use[MESH]|Antineoplastic Agents/therapeutic use[MESH]|Humans[MESH]|Immunosuppressive Agents/therapeutic use[MESH]|Leukemia, Myeloid/diagnosis/etiology/*therapy[MESH]|Middle Aged[MESH]|Risk Factors[MESH] |
